221 related articles for article (PubMed ID: 11252157)
1. Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine.
Turchan J; Anderson C; Hauser KF; Sun Q; Zhang J; Liu Y; Wise PM; Kruman I; Maragos W; Mattson MP; Booze R; Nath A
BMC Neurosci; 2001; 2():3. PubMed ID: 11252157
[TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus-1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function.
Maragos WF; Young KL; Turchan JT; Guseva M; Pauly JR; Nath A; Cass WA
J Neurochem; 2002 Nov; 83(4):955-63. PubMed ID: 12421368
[TBL] [Abstract][Full Text] [Related]
3. Gonadal steroids differentially modulate neurotoxicity of HIV and cocaine: testosterone and ICI 182,780 sensitive mechanism.
Kendall SL; Anderson CF; Nath A; Turchan-Cholewo J; Land CL; Mactutus CF; Booze RM
BMC Neurosci; 2005 Jun; 6():40. PubMed ID: 15943860
[TBL] [Abstract][Full Text] [Related]
4. 17beta-estradiol protects SH-SY5Y Cells against HIV-1 gp120-induced cell death: evidence for a role of estrogen receptors.
Russo R; Navarra M; Maiuolo J; Rotiroti D; Bagetta G; Corasaniti MT
Neurotoxicology; 2005 Oct; 26(5):905-13. PubMed ID: 15899520
[TBL] [Abstract][Full Text] [Related]
5. Increased vulnerability of ApoE4 neurons to HIV proteins and opiates: protection by diosgenin and L-deprenyl.
Turchan-Cholewo J; Liu Y; Gartner S; Reid R; Jie C; Peng X; Chen KC; Chauhan A; Haughey N; Cutler R; Mattson MP; Pardo C; Conant K; Sacktor N; McArthur JC; Hauser KF; Gairola C; Nath A
Neurobiol Dis; 2006 Jul; 23(1):109-19. PubMed ID: 16697650
[TBL] [Abstract][Full Text] [Related]
6. Different effects of selective dopamine uptake inhibitors, GBR 12909 and WIN 35428, on HIV-1 Tat toxicity in rat fetal midbrain neurons.
Aksenov MY; Aksenova MV; Silvers JM; Mactutus CF; Booze RM
Neurotoxicology; 2008 Nov; 29(6):971-7. PubMed ID: 18606182
[TBL] [Abstract][Full Text] [Related]
7. Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine.
Nath A; Haughey NJ; Jones M; Anderson C; Bell JE; Geiger JD
Ann Neurol; 2000 Feb; 47(2):186-94. PubMed ID: 10665489
[TBL] [Abstract][Full Text] [Related]
8. Dopamine transporter as a marker of neuroprotection in methamphetamine-lesioned mice treated acutely with estradiol.
D'Astous M; Gajjar TM; Dluzen DE; Di Paolo T
Neuroendocrinology; 2004; 79(6):296-304. PubMed ID: 15249736
[TBL] [Abstract][Full Text] [Related]
9. Cocaine-mediated enhancement of Tat toxicity in rat hippocampal cell cultures: the role of oxidative stress and D1 dopamine receptor.
Aksenov MY; Aksenova MV; Nath A; Ray PD; Mactutus CF; Booze RM
Neurotoxicology; 2006 Mar; 27(2):217-28. PubMed ID: 16386305
[TBL] [Abstract][Full Text] [Related]
10. D1/NMDA receptors and concurrent methamphetamine+ HIV-1 Tat neurotoxicity.
Aksenov MY; Aksenova MV; Mactutus CF; Booze RM
J Neuroimmune Pharmacol; 2012 Sep; 7(3):599-608. PubMed ID: 22552781
[TBL] [Abstract][Full Text] [Related]
11. Ceftriaxone protects against the neurotoxicity of human immunodeficiency virus proteins.
Rumbaugh JA; Li G; Rothstein J; Nath A
J Neurovirol; 2007 Apr; 13(2):168-72. PubMed ID: 17505985
[TBL] [Abstract][Full Text] [Related]
12. Estrogen attenuates gp120- and tat1-72-induced oxidative stress and prevents loss of dopamine transporter function.
Wallace DR; Dodson S; Nath A; Booze RM
Synapse; 2006 Jan; 59(1):51-60. PubMed ID: 16237680
[TBL] [Abstract][Full Text] [Related]
13. Methamphetamine toxicity and its implications during HIV-1 infection.
Silverstein PS; Shah A; Gupte R; Liu X; Piepho RW; Kumar S; Kumar A
J Neurovirol; 2011 Oct; 17(5):401-15. PubMed ID: 21786077
[TBL] [Abstract][Full Text] [Related]
14. Methamphetamine and human immunodeficiency virus protein Tat synergize to destroy dopaminergic terminals in the rat striatum.
Theodore S; Cass WA; Maragos WF
Neuroscience; 2006 Feb; 137(3):925-35. PubMed ID: 16338084
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of mixed lineage kinase 3 prevents HIV-1 Tat-mediated neurotoxicity and monocyte activation.
Sui Z; Fan S; Sniderhan L; Reisinger E; Litzburg A; Schifitto G; Gelbard HA; Dewhurst S; Maggirwar SB
J Immunol; 2006 Jul; 177(1):702-11. PubMed ID: 16785569
[TBL] [Abstract][Full Text] [Related]
16. Substance P and cholecystokinin regulate neurochemical responses to cocaine and methamphetamine in the striatum.
Loonam TM; Noailles PA; Yu J; Zhu JP; Angulo JA
Life Sci; 2003 Jun; 73(6):727-39. PubMed ID: 12801594
[TBL] [Abstract][Full Text] [Related]
17. EGCG mitigates neurotoxicity mediated by HIV-1 proteins gp120 and Tat in the presence of IFN-gamma: role of JAK/STAT1 signaling and implications for HIV-associated dementia.
Giunta B; Obregon D; Hou H; Zeng J; Sun N; Nikolic V; Ehrhart J; Shytle D; Fernandez F; Tan J
Brain Res; 2006 Dec; 1123(1):216-225. PubMed ID: 17078933
[TBL] [Abstract][Full Text] [Related]
18. Molecular basis for interactions of HIV and drugs of abuse.
Nath A; Hauser KF; Wojna V; Booze RM; Maragos W; Prendergast M; Cass W; Turchan JT
J Acquir Immune Defic Syndr; 2002 Oct; 31 Suppl 2():S62-9. PubMed ID: 12394784
[TBL] [Abstract][Full Text] [Related]
19. Tamoxifen abolishes estrogen's neuroprotective effect upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system.
Gao X; Dluzen DE
Neuroscience; 2001; 103(2):385-94. PubMed ID: 11246153
[TBL] [Abstract][Full Text] [Related]
20. Estradiol protects mesencephalic dopaminergic neurons from oxidative stress-induced neuronal death.
Sawada H; Ibi M; Kihara T; Urushitani M; Akaike A; Shimohama S
J Neurosci Res; 1998 Dec; 54(5):707-19. PubMed ID: 9843162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
